Vicente-Gutierrez C, Bonora N, Bobo-Jimenez V, Jimenez-Blasco D, Lopez-Fabuel I, Fernandez E, et al
As of mid-2025, retatrutide does not have an approved brand name, as it has not yet received marketing authorisation from any regulatory body, including the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK or the European Medicines Agency (EMA)
Its possible that you might be suffering from brain fog, a common cognitive condition that affects more than 25% of adults [1]
This corresponded with a delayed increase in subjective feeling after alcohol consumption
Patients who see dramatic drops in their hemoglobin A1c within weeks face higher risk than those whose diabetes control improves slowly over months